The U.S. Food and Drug Administration has approved Opzelura cream 1.5% (ruxolitinib) for children ages 2 to 11 years with ...

We spoke to dermatologists and conducted research to pick the best lotions for eczema, including picks from brands like ...

It can be hard to feel good about your skin care routine when so many products come in plastic and you’re constantly pushed ...

"Her sweetness shone through any discomfort she may have been feeling," a spokesperson for the shelter told Newsweek.

Greater baseline EASI scores and greater BMI are associated with poor response to lebrikizumab among patients with moderate to severe AD.

The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.